Pantamed sp. z o o. Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2001
NCT00161824
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

PANTAMED sp. z o o.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Encephalitis (Phase 3)

Encephalitis, Tick-Borne (Phase 3)

Influenza, Human (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3